Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Ileal neoplasms
MeSH D007078 - ileal neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007414:
Intestinal neoplasms
0 Companies
0 Drugs
Success rate
D007077:
Ileal diseases
0 Companies
0 Drugs
Success rate
D007078:
Ileal neoplasms
4 Companies
6 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
4/4
Approved:
4
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Interferon alfa-2a
,
Peginterferon alfa-2a
,
Ribavirin
Merck & Co
Interferon alfa-2b
,
Peginterferon alfa-2b
,
Ribavirin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use